Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Binns

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Cancer Research|November 4, 2005
An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug developmentCarleen Cullinane, Donna S Dorow, Maya Kansara, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 2, 2013
The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: results of a prospective study with mature survival dataMichael P Mac Manus, Sarah Everitt, Mike Bayne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 16, 2013
The impact of time between staging PET/CT and definitive chemo-radiation on target volumes and survival in patients with non-small cell lung cancerSarah Everitt, Nikki Plumridge, Alan Herschtal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2014
Differential (18)F-FDG and (18)F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung CancerSarah J Everitt, David L Ball, Rodney J Hicks, et al.
Current Radiopharmaceuticals|March 16, 2017
β -[<sup>18</sup>F]Fluoro Azomycin Arabinoside (β -[<sup>18</sup>F]FAZA): Synthesis, Radiofluorination and Preliminary PET Imaging of Murine A431 TumorsPiyush Kumar, Peter Roselt, Gerald Reischl, et al.
Inorganic Chemistry|March 15, 2019
Modification of Biodistribution and Brain Uptake of Copper Bis(thiosemicarbazonato) Complexes by the Incorporation of Amine and Polyamine Functional GroupsBrett M Paterson, Carleen Cullinane, Peter J Crouch, et al.
Journal of Medical Imaging and Radiation Oncology|February 18, 2014
Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancerMateya E Trinkaus, Rodney J Hicks, Richard J Young, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 30, 2015
Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patientsElske Quak, Pierre-Yves Le Roux, Michael S Hofman, et al.
Journal of Medical Imaging and Radiation Oncology|July 23, 2013
Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapyMateya E Trinkaus, Rob Blum, Danny Rischin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2012
Sex and SUVmax: sex-dependent prognostication in early non-small cell lung cancerZoe Wainer, Marissa G Daniels, Jason Callahan, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Cancer Research|November 4, 2005
An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug developmentCarleen Cullinane, Donna S Dorow, Maya Kansara, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 2, 2013
The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: results of a prospective study with mature survival dataMichael P Mac Manus, Sarah Everitt, Mike Bayne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 16, 2013
The impact of time between staging PET/CT and definitive chemo-radiation on target volumes and survival in patients with non-small cell lung cancerSarah Everitt, Nikki Plumridge, Alan Herschtal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2014
Differential (18)F-FDG and (18)F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung CancerSarah J Everitt, David L Ball, Rodney J Hicks, et al.
Current Radiopharmaceuticals|March 16, 2017
β -[<sup>18</sup>F]Fluoro Azomycin Arabinoside (β -[<sup>18</sup>F]FAZA): Synthesis, Radiofluorination and Preliminary PET Imaging of Murine A431 TumorsPiyush Kumar, Peter Roselt, Gerald Reischl, et al.
Inorganic Chemistry|March 15, 2019
Modification of Biodistribution and Brain Uptake of Copper Bis(thiosemicarbazonato) Complexes by the Incorporation of Amine and Polyamine Functional GroupsBrett M Paterson, Carleen Cullinane, Peter J Crouch, et al.
Journal of Medical Imaging and Radiation Oncology|February 18, 2014
Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancerMateya E Trinkaus, Rodney J Hicks, Richard J Young, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 30, 2015
Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patientsElske Quak, Pierre-Yves Le Roux, Michael S Hofman, et al.
Journal of Medical Imaging and Radiation Oncology|July 23, 2013
Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapyMateya E Trinkaus, Rob Blum, Danny Rischin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2012
Sex and SUVmax: sex-dependent prognostication in early non-small cell lung cancerZoe Wainer, Marissa G Daniels, Jason Callahan, et al.
Pageof 6